Hynek Kasl is a CTO at XENO Cell Innovations, where he co-leads technical innovation of the synthetic biology line of products, including the development of drug screening platforms and advanced biosensors. Hynek has 8 years of experience in Synthetic Biology and was a founding member of the first Czech iGEM team. Hynek is driven by unexpected solutions provided by his truly interdisciplinary intuition developed through persistent work at the intersection of bioengineering, mathematics, and physics. His approach involves foundational development of ideas using rigorous mathematical analysis backed by experimental evidence.
Hynek KaslNoeleen O'Hara